Recital 26, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

The Parties submit that lactase should not be further segmented by production

technology i.e. using genetic modification technology or not for the following reasons. First, from the demand side, GM and non-GM produced lactases can be used interchangeably except for customers wishing to put organic claims on their end products. The Parties submit that the proportion of lactase that goes into organic dairy production accounts for less than 10% of lactase sold both at a global and at EEA scale, meaning that more than 90% of customers can use non-GM and GM produced lactase interchangeably.33 Second, customers can switch relatively quickly (under 6 months) and without incurring significant costs.

34 Third, from a supply side substitutability perspective, the Parties submit that the production equipment is the same and that, accordingly, should the manufacturer have the required approval and proper cleaning procedures are observed, it is possible to relatively quickly switch production between GM and non-GM produced lactases.

35 Fourth, the Parties submit that the average prices of GM and non-GM produced lactase are comparable.36